0001640455-21-000030.txt : 20210203 0001640455-21-000030.hdr.sgml : 20210203 20210203175012 ACCESSION NUMBER: 0001640455-21-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trehu Elizabeth CENTRAL INDEX KEY: 0001693456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 21587586 MAIL ADDRESS: STREET 1: C/O JOUNCE THERAPEUTICS, INC. STREET 2: 1030 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_161239258575136.xml FORM 4 X0306 4 2021-02-01 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001693456 Trehu Elizabeth C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common Stock 2021-02-01 4 A 0 22250 0 A 93585 D Stock Option (Right to Buy) 11.89 2021-02-01 4 A 0 44500 0 A 2031-02-01 Common Stock 44500.0 44500 D The option will vest quarterly in 16 equal installments following January 1, 2021. /s/ Kim C. Drapkin, Attorney-in-Fact 2021-02-03